The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment

Details for Australian Patent Application No. 2002253488 (hide)

Owner Schering AG

Inventors Hegele-Hartung, Christa; Beier, Henning, M.; Hess-Stumpp, Holger; Krusche, Claudia

Agent Davies Collison Cave

Pub. Number AU-B-2002253488

PCT Pub. Number WO2002/067910

Priority 09/801,925 09.03.01 US; 09/756,286 09.01.01 US

Filing date 9 January 2002

Wipo publication date 12 September 2002

Acceptance publication date 15 February 2007

International Classifications

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61K 31/567 (2006.01) - substituted in position 17 alpha, e.g. mestranol, norethandrolone

A61K 31/57 (2006.01) - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 15/08 (2006.01) Drugs for genital or sexual disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

6 March 2003 Application Open to Public Inspection

  Published as AU-B-2002253488

15 February 2007 Application Accepted

  Published as AU-B-2002253488

14 June 2007 Standard Patent Sealed

7 August 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002253489-A CATHETER

2002253487-VECTOR DIFFERENCE MEASURES FOR DATA CLASSIFIERS